- £1.87m
- £0.74m
- £0.01m
REG - AIM - AIM Notice - 08/01/2024
AnnouncementREG - ValiRx PLC - Result of GM, Issue of Equity
AnnouncementREG - ValiRx PLC - Result of Retail Offer, Subscription
AnnouncementREG - ValiRx PLC - Posting of Circular, Notice of GM and Ops Review
AnnouncementREG - ValiRx PLC - Conditional Fundraise, Notice of General Meeting
AnnouncementREG - ValiRx PLC - Retail Offer
AnnouncementREG - ValiRx PLC - Agreement to License VAL401 to Ambrose Healthcare
AnnouncementREG - ValiRx PLC - Evaluation Agreement with StingRay Bio
AnnouncementREG - ValiRx PLC - Statement re Share Price Movement
AnnouncementREG - ValiRx PLC - Operational Review
AnnouncementREG - ValiRx PLC - Half-year Report
AnnouncementREG - ValiRx PLC - Collaborative Services Agreement
AnnouncementRCS - ValiRx PLC - Inaphaea BioLabs secures first external contract
AnnouncementREG - ValiRx PLC - Result of AGM
AnnouncementRCS - ValiRx PLC - Virtual AGM Access
AnnouncementRCS - ValiRx PLC - Inaphaea BioLabs Operational Update
AnnouncementREG - ValiRx PLC - Conclusion of Hokkaido Evaluation Agreement
AnnouncementREG - ValiRx PLC - Asset Purchase – Imagen Therapeutics
AnnouncementREG - ValiRx PLC - Update on proposed sub-license of VAL201
Announcement